newsThe Arctos Medical acquisition will expand Novarits’ optogenetics portfolio to…
22 September 2021 | By Anna Begley (European Pharmaceutical Review)
The Arctos Medical acquisition will expand Novarits’ optogenetics portfolio to bring gene therapies to patients with severe vision loss.